BioVie
  • About
    • BioVie (OTC PINK: BIVI)
    • Management Team
    • Medical advisory board
    • IND Team
    • Consultant network
  • Disease Target
    • Ascites
    • Severe complications
    • Current drug therapies
    • How does ascites develop?
  • Technology
    • BIV201 development status
    • Future possibilities
    • Potential access to early-stage compounds
    • Efflux pump antibiotics program
    • Forward looking statements
  • Investors
    • Financial Information
    • Press Releases
  • Contact
    • Subscribe to Website
  • Search
Subscribe to Our Email List

SITE MAP

  • About
    • BioVie (OTC PINK: BIVI)
    • Management Team
    • Medical advisory board
    • IND Team
    • Consultant network
  • Disease Target
    • Ascites
    • Severe complications
    • Current drug therapies
    • How does ascites develop?
  • Technology
    • BIV201 development status
    • Future possibilities
    • Potential access to early-stage compounds
    • Efflux pump antibiotics program
    • Forward looking statements
  • Investors
    • Financial Information
    • Press Releases
  • Contact
    • Subscribe to Website

FOR INQUIRIES

Investors
info@biovieinc.com

Business Development
info@biovieinc.com

Media
info@biovieinc.com

Subscribe to our email list

Subscribe to Our Email List

Contact Info

BioVie Inc.
100 Cummings Center, Suite 247-C
Beverly, Massachusetts 01915
info@biovieinc.com
© 2016 Copyright - BioVie | Terms and Conditions | Privacy Policy
Scroll to top